Results 1 to 10 of about 1,371,297 (262)

Health-related quality of life for adults living with hepatitis B in the United States: a qualitative assessment

open access: yesJournal of Patient-Reported Outcomes, 2021
Background In 2019, an estimated 296 million people were living with chronic hepatitis B virus (HBV) globally with approximately 2.4 million living within the United States.
Catherine Freeland   +6 more
doaj   +1 more source

Hepatic encephalopathy

open access: yesNature Reviews Disease Primers, 2022
Hepatic encephalopathy (HE) is a prognostically relevant neuropsychiatric syndrome that occurs in the course of acute or chronic liver disease. Besides ascites and variceal bleeding, it is the most serious complication of decompensated liver cirrhosis.
Dieter Häussinger   +11 more
openaire   +11 more sources

Awareness and treatment of chronic hepatitis B in Malaysia-findings from a community-based screening campaign

open access: yesBMC Gastroenterology, 2022
Introduction In 2016 the World Health Organization (WHO) had adopted a global strategy to eliminate Hepatitis B (HBV) by 2030 through five core interventions.
Zhuo-zhi Lim   +3 more
doaj   +1 more source

The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?

open access: yesArchives of Public Health, 2021
Background Co-infection between hepatitis B virus (HBV) and hepatitis delta virus (HDV) causes the severest chronic hepatitis and is associated with a high risk of cirrhosis and hepatocellular carcinoma (HCC).
Tomoyuki Hayashi   +10 more
doaj   +1 more source

Trends of the Global Hepatitis C Disease Burden: Strategies to Achieve Elimination [PDF]

open access: yesJournal of Preventive Medicine and Public Health, 2021
Hepatitis C infection is responsible for high morbidity and mortality rates globally as well as for significant indirect costs. The disease burden caused by the hepatitis C virus (HCV) is comparable to the one caused by human immunodeficiency virus or ...
Nathalie Brunner, Philip Bruggmann
doaj   +1 more source

Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study

open access: yesBMC Public Health, 2021
Background An estimated between 257 and 292 million people live with chronic HBV globally. While much is known about the causes, and epidemiology of HBV, little is understood about the quality of life and impact of HBV on those living with the infection.
Catherine Freeland   +8 more
doaj   +1 more source

Autoimmune Hepatitis [PDF]

open access: yesNature Reviews Gastroenterology & Hepatology, 1996
Autoimmune hepatitis is an inflammatory liver disease in which the immune system is believed to orchestrate an immune attack onto the liver cell. Current knowledge suggests that both T helper 1 (TH1) and TH2 programmes are involved in the generation of the liver damage.
Vergani, D, Mieli-Vergani, G
openaire   +12 more sources

Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project

open access: yesHarm Reduction Journal, 2022
Background This commentary explores the lessons learned during implementation of a peer-facilitated hepatitis C virus (HCV) testing and treatment access project called the Live Hep C Free (LHCF) project in contributing to micro-elimination efforts.
Julia A. Silano   +4 more
doaj   +1 more source

P-87 HIGH PREVALENCE OF SARS-COV-2 ANTIBODIES IN PREGNANT WOMEN INFECTED WITH VIRAL HEPATITIS IN BRAZIL

open access: yesAnnals of Hepatology, 2021
Introduction: Pregnant women are considered more vulnerable to viral infections, such as severe viral respiratory infections and viral hepatitis. Data about Brazilian pregnant and postpartum women found a case fatality rate of 12.7% among COVID-19 Acute ...
Alanna Calheiros Santos   +6 more
doaj   +1 more source

P-117 LOW PREVALENCE OF HEPATITIS B AND C AMONG PEOPLE LIVING IN POVERTY IN NORTHEAST BRAZIL

open access: yesAnnals of Hepatology, 2021
Introduction: Hepatitis B and C infection are responsible for more than 300 million of chronic liver disease patients all over the world. One goal of WHO 2030 agenda is the eradication of hepatitis B and C.
Livia Melo Villar   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy